Key Takeaways:
- Agilon Health (AGL, Financial) has significantly outperformed the Medical sector with a 131.6% stock increase this year.
- Despite recent growth, analysts see a potential downside with the current price exceeding the average target.
- GuruFocus estimates a compelling GF Value, indicating substantial upside potential.
Agilon Health (AGL) has captured the attention of investors with a remarkable 131.6% increase in its stock value this year, far surpassing the average 4.9% return of the Medical sector. The company's stellar performance is bolstered by a 21.3% rise in full-year earnings estimates over the past quarter, earning it a Zacks Rank of #2 (Buy).
Wall Street Analysts’ Forecast
In-depth analysis from 15 analysts reveals a one-year average price target for Agilon Health Inc (AGL, Financial) at $3.40, with estimates ranging from a high of $6.00 to a low of $2.00. This average target suggests a potential downside of 36.57% from the current stock price of $5.36. Additional detailed estimates are available on the Agilon Health Inc (AGL) Forecast page.
Consensus recommendations from 22 brokerage firms place Agilon Health Inc's (AGL, Financial) average brokerage recommendation at 3.0, indicating a "Hold" status. On a scale of 1 to 5, where 1 denotes Strong Buy and 5 represents Sell, this rating reflects a cautious market outlook.
GuruFocus Valuation Insights
According to GuruFocus estimates, the projected GF Value for Agilon Health Inc (AGL, Financial) in a year's time is $36.86. This estimate suggests a potential upside of 587.69% from the current price of $5.36. The GF Value is derived from historical trading multiples, past business growth, and anticipated future business performance. More comprehensive information can be accessed on the Agilon Health Inc (AGL) Summary page.
